Maraffi, I.; Mallucci, G.; Disanto, G.; Sacco, R.; Tiberti, M.; Gobbi, C.; Zecca, C.
Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis. J. Clin. Med. 2024, 13, 2780.
https://doi.org/10.3390/jcm13102780
AMA Style
Maraffi I, Mallucci G, Disanto G, Sacco R, Tiberti M, Gobbi C, Zecca C.
Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis. Journal of Clinical Medicine. 2024; 13(10):2780.
https://doi.org/10.3390/jcm13102780
Chicago/Turabian Style
Maraffi, Isabella, Giulia Mallucci, Giulio Disanto, Rosaria Sacco, Massimiliano Tiberti, Claudio Gobbi, and Chiara Zecca.
2024. "Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis" Journal of Clinical Medicine 13, no. 10: 2780.
https://doi.org/10.3390/jcm13102780
APA Style
Maraffi, I., Mallucci, G., Disanto, G., Sacco, R., Tiberti, M., Gobbi, C., & Zecca, C.
(2024). Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis. Journal of Clinical Medicine, 13(10), 2780.
https://doi.org/10.3390/jcm13102780